These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3460587)

  • 21. The adverse effects of kava.
    Kava R
    Pac Health Dialog; 2001 Mar; 8(1):115-8. PubMed ID: 12017812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Doctors' prescription behaviour regarding dosage recommendations for preparations of kava extracts.
    Dietlein G; Schröder-Bernhardi D
    Pharmacoepidemiol Drug Saf; 2003; 12(5):417-21. PubMed ID: 12899118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alignment of the policy planets: behind the implementation of the Northern Territory (Australia) Living With Alcohol programme.
    D'Abbs P
    Drug Alcohol Rev; 2004 Mar; 23(1):55-66. PubMed ID: 14965887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical utilization of atypical antipsychotics in pregnancy and lactation.
    Gentile S
    Ann Pharmacother; 2004; 38(7-8):1265-71. PubMed ID: 15150376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells.
    Whittaker P; Clarke JJ; San RH; Betz JM; Seifried HE; de Jager LS; Dunkel VC
    Food Chem Toxicol; 2008 Jan; 46(1):168-74. PubMed ID: 17822821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mescaline and the San Pedro cactus ritual: archaeological and ethnographic evidence in northern Peru].
    Carod-Artal FJ; Vázquez-Cabrera CB
    Rev Neurol; 2006 Apr 16-30; 42(8):489-98. PubMed ID: 16625512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diversity of substance use in eastern Arnhem Land (Australia): patterns and recent changes.
    Clough AR; Guyula T; Yunupingu M; Burns CB
    Drug Alcohol Rev; 2002 Dec; 21(4):349-56. PubMed ID: 12537704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Kava-kava preparations--alternative anxiolytics].
    Nowakowska E; Ostrowicz A; Chodera A
    Pol Merkur Lekarski; 1998 Mar; 4(21):179-180a. PubMed ID: 9640076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of psychotropic medications on hypothalamic-pituitary-adrenal regulation.
    Meador-Woodruff JH; Greden JF
    Neurol Clin; 1988 Feb; 6(1):225-34. PubMed ID: 2898096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dental self-care and dietary characteristics of remote-living Indigenous children.
    Jamieson LM; Bailie RS; Beneforti M; Koster CR; Spencer AJ
    Rural Remote Health; 2006; 6(2):503. PubMed ID: 16646637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the heavy usage of kava on physical health: summary of a pilot survey in an aboriginal community.
    Mathews JD; Riley MD; Fejo L; Munoz E; Milns NR; Gardner ID; Powers JR; Ganygulpa E; Gununuwawuy BJ
    Med J Aust; 1988 Jun; 148(11):548-55. PubMed ID: 3374423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The world's longest surviving paediatric practices: some themes of Aboriginal medical ethnobotany in Australia.
    Pearn J
    J Paediatr Child Health; 2005; 41(5-6):284-90. PubMed ID: 15953330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community attitudes toward public policies to control alcohol, tobacco, and high-fat food consumption.
    Jeffery RW; Forster JL; Schmid TL; McBride CM; Rooney BL; Pirie PL
    Am J Prev Med; 1990; 6(1):12-9. PubMed ID: 2340187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Differences in the subjective effects of drugs in patients with a first psychotic episode. Preliminary results].
    Busquets E; Torrens M; Soler A; Farré M; Bulbena A
    Actas Esp Psiquiatr; 2005; 33(1):19-25. PubMed ID: 15704027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminative-stimulus and time-course effects of kava-kava (Piper methysticum) in rats.
    Bruner NR; Anderson KG
    Pharmacol Biochem Behav; 2009 Apr; 92(2):297-303. PubMed ID: 19159643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kava use in Australia.
    Prescott J
    Drug Alcohol Rev; 1990; 9(4):325-8. PubMed ID: 16840159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of heavy usage of kava on physical health.
    Med J Aust; 1988 Sep; 149(6):341-2. PubMed ID: 3419385
    [No Abstract]   [Full Text] [Related]  

  • 38. Some visual effects caused by the beverage kava.
    Garner LF; Klinger JD
    J Ethnopharmacol; 1985 Jul; 13(3):307-11. PubMed ID: 4058033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of public opinion towards alcohol controls in Australia.
    Tobin C; Moodie AR; Livingstone C
    BMC Public Health; 2011 Jan; 11():58. PubMed ID: 21272368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Australians support industry to tackle alcohol abuse.
    Aust Nurs Midwifery J; 2015 Jun; 22(11):34. PubMed ID: 26451453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.